Results 211 to 220 of about 211,802 (307)

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

British Journal of Clinical Pharmacology, EarlyView.
Aim Clinically, interstitial lung disease (ILD) is a heterogeneous group of respiratory disorders. Due to their low incidence, pharmacovigilance database analysis is useful to detect them. Precise diagnosis is challenging as well as coding in these databases. Query criteria are among the key elements for a good signal detection.
Romane Freppel, Adeline Benis, Philippe Bonniaud, Jean‐Luc Faillie, Aurélie Grandvuillemin   +4 more
wiley   +1 more source

Health-Related Social Needs during the COVID-19 Pandemic: The Chronic Renal Insufficiency Cohort (CRIC) Study. [PDF]

Kidney360
Novick TK, Osuna-Diaz M, Appel LJ, Charleston JB, Lash JP, Meza N, Cohen DL, Allen A, Crews DC, CRIC Study Investigators.   +9 more
europepmc   +1 more source

Renal function after conversion from cyclosporine to FK 506 in liver transplant patients [PDF]

, 1991
Brown, H, Deballi, P, Fung, JJ, Jain, A, McCauley, J, Starzl, TE, Todo, S   +6 more
core  

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source

Utilization of SYNTAX Score II for Predictive Clinical Outcomes in Patients with Coronary Artery Disease and Chronic Renal Insufficiency Following Percutaneous Coronary Intervention. [PDF]

Rev Cardiovasc Med
Yan L, Han D, Wang Y, Li S, Yan W, Guo N, Mao Y, Yang Q, Li M, Lei Y, Zhang S, Cao F.   +11 more
europepmc   +1 more source

Weaning of immunosuppression in long-term recipients of living related renal transplants: A preliminary study [PDF]

, 1995
Fung, JJ, Mazariegos, GV, Ramos, H, Shapiro, R, Starzl, TE, Zeevi, A   +5 more
core  

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19

British Journal of Clinical Pharmacology, EarlyView.
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman, Laura Buggiotti, Li‐An K. Brown, Jose A. Guerra‐Assuncao, Japhette E. Kembou‐Ringert, Wen Y. Mak, Judith Breuer, David M. Lowe, Joseph F. Standing, FLARE Investigators   +9 more
wiley   +1 more source

Organic Pollutant Exposure and CKD: A Chronic Renal Insufficiency Cohort Pilot Study. [PDF]

Kidney Med
Charytan DM, Wu W, Liu M, Li ZM, Kannan K, Trasande L, Pal VK, Lee S, Trachtman H, CRIC Study Investigators.   +9 more
europepmc   +1 more source

Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children

British Journal of Clinical Pharmacology, EarlyView.
This systematic review identified 112 population pharmacokinetic models of vancomycin in neonates and children. To support rational model selection for model‐informed precision, we developed and applied expert‐driven, transparent criteria that integrate both methodological rigour and clinical relevance.
Zoë Vander Elst, Pieter‐Jan Spiessens, Dorian Vanneste, Nada Dia, Matthias Gijsen, Isabel Spriet, Karel Allegaert, Erwin Dreesen, Anne Smits   +8 more
wiley   +1 more source

The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience. [PDF]

Breast Cancer
Hong YW, Kuo IM, Kuo WL, Yu CC, Shen SC, Tsai HP, Chu CH, Ho HY, Lo YF, Chen SC, Lin YC, Chien CY, Chou HH.   +12 more
europepmc   +1 more source